OraSolv Products

RLS Global (formerly OraSolv Products AB) was a Swedish medical technology company specializing in biochemical products for advanced wound care and minimally invasive dentistry. The company's core technology was a unique hypochlorite-based platform used to develop products like ChloraSolv, a debriding gel for chronic wounds such as diabetic foot ulcers, and Carisolv, a method for tissue-preserving caries removal. Despite establishing partnerships with companies like ConvaTec, RLS Global faced severe financial difficulties and filed for bankruptcy in November 2023, leading to its delisting from the Nasdaq First North Growth Market. The company's products were designed to offer minimally invasive alternatives to traditional mechanical treatments, focusing on tissue preservation and improved patient outcomes.